Aerie Pharmaceuticals (AERI) рентабельность EBITDA US GAAP (годовые значения)

2017 2018 2019 2020 2021   LTM ? CAGR 5 лет ?
Рентаб EBITDA, % ? -941.2% -238.0% -141.0% -4.02%   -1.44%  
Изм. за год, г/г, % +703пп +97пп +137пп     -83.8%

Aerie Pharmaceuticals. Рентаб EBITDA, %

Created with Highcharts 6.0.6-941.2-941.2-238.0-238.0-141.0-141.0-4.0-4.0-1.4-1.42018201920202021LTM-1000-800-600-400-2000smart-lab.ru

Aerie Pharmaceuticals. Рентаб EBITDA, изменение, пп

Created with Highcharts 6.0.6703.3703.397.097.0137.0137.02.62.6201920202021LTM0200400600800smart-lab.ru

Aerie Pharmaceuticals (AERI) рентабельность EBITDA US GAAP (квартальные значения)

2021Q3 2021Q4 2022Q1 2022Q2 2022Q3   LTM ?
Рентаб EBITDA, % ? -77.3% 55.2% -100.4% -44.2% -60.2%   -1.44%
Изм. за год, г/г, % +44пп +157пп +13пп +38пп +17пп    
Изм. за квартал, к/к, % +5пп +133пп -156пп +56пп -16пп    

Aerie Pharmaceuticals. Рентаб EBITDA, %

Created with Highcharts 6.0.6-2227.2-2227.2-831.1-831.1-354.3-354.3-410.7-410.7-262.9-262.9-252.5-252.5-143.7-143.7-170.2-170.2-189.6-189.6-121.0-121.0-101.4-101.4-113.7-113.7-82.2-82.2-77.3-77.355.255.2-100.4-100.4-44.2-44.2-60.2-60.22018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q3-2500-2000-1500-1000-5000500smart-lab.ru

Aerie Pharmaceuticals. Рентаб EBITDA, изменение, пп

Created with Highcharts 6.0.61964.31964.3578.6578.6210.6210.6240.6240.673.473.4131.6131.642.442.456.456.4107.4107.443.643.6156.6156.613.313.338.038.017.217.22019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q305001000150020002500smart-lab.ru

Aerie Pharmaceuticals. Рентаб EBITDA, изменение, пп

Created with Highcharts 6.0.61396.11396.1476.9476.9-56.5-56.5147.8147.810.410.4108.8108.8-26.4-26.4-19.4-19.468.668.619.619.6-12.4-12.431.531.54.94.9132.6132.6-155.6-155.656.256.2-16.0-16.02018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q3-2500250500750100012501500smart-lab.ru
Чтобы купить акции, выберите надежного брокера: